# Johnson & Johnson (JNJ) P/S ratio: 7.2× today

URL: https://funkfolio.com/stock/JNJ/ps-ratio

> Johnson & Johnson (JNJ) P/S ratio is 7.2× today, against 5.3× at the end of fiscal 2025. Its median over 19 fiscal year-ends is 4.2×.

---

## Johnson & Johnson (JNJ) P/S ratio

**P/S ratio today:** 7.2× as of Nov 18, 2026, 9:31 AM UTC

Johnson & Johnson (JNJ) trades at 7.2× its revenue per share for fiscal 2025. At the end of fiscal 2025 (December 31, 2025) its P/S ratio was 5.3×. That is 34.9% higher than the 4.0× of fiscal 2024. Figures as of 18 Nov 2026, 09:31 UTC, from the company's filings with the SEC and Yahoo Finance.

### Key facts

- **P/S ratio today:** 7.2×
- **P/S ratio, fiscal 2025:** 5.3×
- **Change on fiscal 2024:** +34.9%
- **Highest on record:** 5.9× fiscal 2022
- **Lowest on record:** 2.7× fiscal 2008
- **Fiscal years on record:** 19 2007–2025

Figures as of 18 Nov 2026, 09:31 UTC. Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

### Johnson & Johnson P/S ratio, in more detail

Today's figure is 34.7% above the fiscal 2025 year-end.

Across the 19 fiscal year-ends on record (2007–2025), the highest was 5.9× in fiscal 2022 and the lowest 2.7× in fiscal 2008. Today's P/S ratio is above every one of the 19 fiscal year-ends on record; their median is 4.2×.

### P/S ratio at each fiscal year-end

The last point is today's figure; the others are fiscal year-ends.

### Johnson & Johnson P/S ratio, year by year

Johnson & Johnson (JNJ) P/S ratio by fiscal year

| Fiscal year | P/S ratio | Change | Year ended | Share price at year-end | Revenue per share |
| --- | --- | --- | --- | --- | --- |
| Today | 7.2× | — | Nov 18, 2026 | $278.70 | — |
| 2025 | 5.3× | 34.9% up | Dec 31, 2025 | $206.95 | $38.77 |
| 2024 | 4.0× | 16.1% down | Dec 31, 2024 | $144.62 | $36.56 |
| 2023 | 4.7× | 19.9% down | Dec 31, 2023 | $156.74 | $33.26 |
| 2022 | 5.9× | — | Dec 31, 2022 | $176.65 | $30.03 |
| 2022 | 5.9× | 10.9% up | Jan 2, 2022 | $172.29 | $29.45 |
| 2021 | 5.3× | — | Jan 3, 2021 | $163.13 | $30.92 |
| 2019 | 4.8× | 10.5% up | Dec 29, 2019 | $145.87 | $30.57 |
| 2018 | 4.3× | 14.0% down | Dec 30, 2018 | $129.05 | $29.90 |
| 2017 | 5.0× | — | Dec 31, 2017 | $139.72 | $27.85 |
| 2017 | 4.5× | 6.6% up | Jan 1, 2017 | $115.21 | $25.78 |
| 2016 | 4.2× | — | Jan 3, 2016 | $104.44 | $24.91 |
| 2014 | 4.0× | 9.0% up | Dec 28, 2014 | $104.57 | $25.95 |
| 2013 | 3.7× | 26.0% up | Dec 29, 2013 | $91.59 | $24.79 |
| 2012 | 2.9× | — | Dec 30, 2012 | $70.10 | $23.90 |
| 2012 | 2.8× | 3.4% up | Jan 1, 2012 | $65.58 | $23.43 |
| 2011 | 2.7× | 4.4% down | Jan 2, 2011 | $59.77 | $22.08 |
| 2010 | 2.8× | — | Jan 3, 2010 | $62.86 | $22.19 |
| 2008 | 2.7× | 16.2% down | Dec 28, 2008 | $59.83 | $22.48 |
| 2007 | 3.2× | — | Dec 30, 2007 | $66.70 | $20.99 |

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

### How it is calculated

The P/S ratio is the share price divided by revenue per share — the same thing as market value divided by revenue — taken at each fiscal year-end.

### How to read it

It prices each unit of sales and still works when there is no profit; what counts as high depends on the margin those sales earn.

### P/S ratio at health care companies of similar size

P/S ratio of Johnson & Johnson and comparable companies

| Company | P/S ratio |
| --- | --- |
| [Eli Lilly LLY](https://funkfolio.com/stock/LLY/ps-ratio) | 19.3× |
| Johnson & Johnson JNJ | 7.1× |
| [AbbVie ABBV](https://funkfolio.com/stock/ABBV/ps-ratio) | 8.5× |
| [Merck & Co MRK](https://funkfolio.com/stock/MRK/ps-ratio) | 5.4× |
| [UnitedHealth Group UNH](https://funkfolio.com/stock/UNH/ps-ratio) | 0.8× |
| [Novartis NVS](https://funkfolio.com/stock/NVS/ps-ratio) | 5.3× |

Today's market value divided by revenue for the latest fiscal year. A company whose statements are in another currency than its shares is left out.

### Johnson & Johnson, figure by figure

- [Johnson & Johnson market cap](https://funkfolio.com/stock/JNJ/market-cap)
- [Johnson & Johnson revenue](https://funkfolio.com/stock/JNJ/revenue)
- [Johnson & Johnson earnings](https://funkfolio.com/stock/JNJ/earnings)
- [Johnson & Johnson earnings per share (EPS)](https://funkfolio.com/stock/JNJ/eps)
- [Johnson & Johnson P/E ratio](https://funkfolio.com/stock/JNJ/pe-ratio)
- [Johnson & Johnson P/B ratio](https://funkfolio.com/stock/JNJ/pb-ratio)
- [Johnson & Johnson free cash flow](https://funkfolio.com/stock/JNJ/free-cash-flow)
- [Johnson & Johnson operating margin](https://funkfolio.com/stock/JNJ/operating-margin)
- [Johnson & Johnson dividend](https://funkfolio.com/stock/JNJ/dividend)
- [Johnson & Johnson shares outstanding](https://funkfolio.com/stock/JNJ/shares-outstanding)
- [Johnson & Johnson total debt](https://funkfolio.com/stock/JNJ/total-debt)
- [Johnson & Johnson cash on hand](https://funkfolio.com/stock/JNJ/cash)
- [Johnson & Johnson total assets](https://funkfolio.com/stock/JNJ/total-assets)
- [Johnson & Johnson return on equity (ROE)](https://funkfolio.com/stock/JNJ/roe)
- [Johnson & Johnson return on invested capital (ROIC)](https://funkfolio.com/stock/JNJ/roic)

[Johnson & Johnson (JNJ) overview: price, valuation and scorecard](https://funkfolio.com/stock/JNJ) [All health care companies by market value](https://funkfolio.com/companies/sector/health-care)

### Johnson & Johnson P/S ratio: questions and answers

**What is Johnson & Johnson's P/S ratio?**

Johnson & Johnson (JNJ) trades at 7.2× its revenue per share for fiscal 2025. At the end of fiscal 2025 (December 31, 2025) its P/S ratio was 5.3×. That is 34.9% higher than the 4.0× of fiscal 2024.

**Is Johnson & Johnson's P/S ratio high or low compared with its own history?**

Today's P/S ratio is above every one of the 19 fiscal year-ends on record; their median is 4.2×.

**What are the highest and lowest P/S ratio figures on record for Johnson & Johnson?**

Across the 19 fiscal year-ends on record (2007–2025), the highest was 5.9× in fiscal 2022 and the lowest 2.7× in fiscal 2008.

**How is Johnson & Johnson's P/S ratio calculated?**

The P/S ratio is the share price divided by revenue per share — the same thing as market value divided by revenue — taken at each fiscal year-end. For Johnson & Johnson it is on record here for 19 fiscal years, 2007 to 2025.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

### Learn: P/S ratio

[All stocks guides →](https://funkfolio.com/learn/stocks)

- [P/E ratio explained: what a high or low figure means](https://funkfolio.com/learn/stocks/pe-ratio)

  The price-to-earnings (P/E) ratio is a share's price divided by its earnings per share. A stock at $100 earning $5 a share has a P/E of 20: buyers pay $20 for each dollar of yearly profit. A high P/E usually means the market expects profit to grow; a low one can mean doubt, not a bargain.
- [Revenue vs earnings vs free cash flow: what each tells you](https://funkfolio.com/learn/stocks/revenue-earnings-free-cash-flow)

  Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- [Altman Z-score: formula, zones and where it fails](https://funkfolio.com/learn/stocks/altman-z-score)

  The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.

### Cite this page

Funkfolio, “Johnson & Johnson (JNJ) P/S ratio”, data as of 18 November 2026. https://funkfolio.com/stock/JNJ/ps-ratio

Underlying data: the company's filings with the SEC and Yahoo Finance.
